Franklin Covey tumbles 24% on lowered revenue guidance as Q3 results disappoint

Franklin Covey (FC) shares fell 24% after it missed Q3 adjusted EPS ($0.27 vs $0.29) and revenue ($67.8M vs $68.59M), and cut fiscal 2026 revenue guidance to $260M-$267M (midpoint $263.5M vs $267.76M consensus). The guidance reduction cites a timing shift in an Enterprise North America services contract, Education hit from state budget cuts, and weaker international conditions amid geopolitical tensions. Despite the revenue miss, the company kept adjusted EBITDA guidance at $28M-$31M (within the prior range) and reported liquidity of $74M+.

Analysis

The selloff looks more like a multiple reset than an earnings-quality collapse. Management held EBITDA guidance while cutting revenue, which implies the market is now pricing in lower top-line visibility rather than a near-term margin problem; that usually compresses EV/revenue more than EV/EBITDA, and small-cap names with thin liquidity tend to overshoot on that distinction.

The second-order read is less about FC itself and more about budget timing across corporate learning and public-sector education spend. If a single enterprise contract can push revenue into a later period, then peers with similar project-style revenue recognition should be vulnerable to the same booking-to-bill slippage; conversely, more diversified subscription or platform models can look relatively safer. The deferred revenue build is the important tell: it argues demand may be delayed, not destroyed, which reduces the probability of a sustained fundamental break unless invoiced growth rolls over again.

Near term, the stock is vulnerable to another leg down if the next update shows the revenue cadence problem spreading beyond one contract or if international softness worsens into outright cancellations. Over 1-3 months, the key catalyst is whether enterprise invoicing converts back into revenue; over 6-18 months, the thesis becomes whether FC can re-accelerate without relying on lumpy state/large-account deals. The consensus may be missing that the downside from here is likely capped unless guidance is cut again, but the upside is also limited until the company proves conversion velocity is normalizing.

Key Decisions for Investors

• Do not chase the gap-down short immediately; wait for 1-2 sessions of price/volume stabilization. If FC holds the post-earnings low and management does not cut EBITDA again, the stock can mean-revert 10-15% just from sentiment normalization.
• Relative-value idea: short FC / long KFY as a quality-vs-execution pair. FC has more contract-timing and budget sensitivity, while KFY offers a more diversified revenue mix; target a 10-20% spread move over 1-3 months if FC’s bookings remain choppy.
• Set a catalyst alert rather than a blind short: if next quarter invoiced growth stays below ~5% or FY26 revenue guidance is cut again, shift to an outright short in FC. That would confirm demand degradation rather than simple timing.
• For accounts willing to take contrarian risk, consider a small tactical long only after FC reclaims the post-event breakdown level and management proves revenue conversion is back on track. Risk/reward is attractive only if the selloff was an overreaction; stop out if guidance is revised down again.